These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 11255695

  • 1. [Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension].
    Shimoyama M, Hayashi D, Zou Y, Takimoto E, Mizukami M, Monzen K, Yazaki Y, Nagai R, Komuro I.
    J Cardiol; 2001 Feb; 37(2):114-8. PubMed ID: 11255695
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension.
    Shimoyama M, Hayashi D, Zou Y, Takimoto E, Mizukami M, Monzen K, Kudoh S, Hiroi Y, Yazaki Y, Nagai R, Komuro I.
    Circulation; 2000 Oct 17; 102(16):1996-2004. PubMed ID: 11034951
    [Abstract] [Full Text] [Related]

  • 3. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Noda A, Izawa H, Nagata K, Yokota M.
    Clin Exp Pharmacol Physiol; 2006 Dec 17; 33(12):1164-71. PubMed ID: 17184496
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder.
    Kamiya H, Okumura K, Ito M, Saburi Y, Tomida T, Hayashi K, Matsui H, Hayakawa T.
    Can J Cardiol; 2001 Dec 17; 17(12):1292-8. PubMed ID: 11773940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats.
    Nomura M, Nomura S, Mitsui T, Suzuki M, Kobayashi H, Ito T, Itakura A, Kikkawa F, Mizutani S.
    Am J Hypertens; 2005 Apr 17; 18(4 Pt 1):538-43. PubMed ID: 15831365
    [Abstract] [Full Text] [Related]

  • 8. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
    Nagata K, Somura F, Obata K, Odashima M, Izawa H, Ichihara S, Nagasaka T, Iwase M, Yamada Y, Nakashima N, Yokota M.
    Hypertension; 2002 Aug 17; 40(2):168-74. PubMed ID: 12154108
    [Abstract] [Full Text] [Related]

  • 9. Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats.
    Louhelainen M, Merasto S, Finckenberg P, Vahtola E, Kaheinen P, Leskinen H, Levijoki J, Pollesello P, Haikala H, Mervaala EM.
    J Physiol Pharmacol; 2009 Sep 17; 60(3):41-7. PubMed ID: 19826180
    [Abstract] [Full Text] [Related]

  • 10. Blockade of calcineurin reverses cardiac hypertrophy and induces the down-regulation of JNK mRNA expression in renovascular hypertensive rats.
    Hongzhuan Sheng, Jianhua Zhu, Xiaohui Wu, Jinan Zhang.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep 17; 9(3):139-45. PubMed ID: 18957384
    [Abstract] [Full Text] [Related]

  • 11. Rat chromosome 19 transfer from SHR ameliorates hypertension, salt-sensitivity, cardiovascular and renal organ damage in salt-sensitive Dahl rats.
    Wendt N, Schulz A, Siegel AK, Weiss J, Wehland M, Sietmann A, Kossmehl P, Grimm D, Stoll M, Kreutz R.
    J Hypertens; 2007 Jan 17; 25(1):95-102. PubMed ID: 17143179
    [Abstract] [Full Text] [Related]

  • 12. Cardiac calcineurin during transition from hypertrophy to heart failure in rats.
    Hayashida W, Kihara Y, Yasaka A, Sasayama S.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):347-51. PubMed ID: 10873609
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of Ca2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy.
    Zobel C, Rana OR, Saygili E, Bölck B, Saygili E, Diedrichs H, Reuter H, Frank K, Müller-Ehmsen J, Pfitzer G, Schwinger RH.
    Cardiology; 2007 Jun 24; 107(4):281-90. PubMed ID: 17264507
    [Abstract] [Full Text] [Related]

  • 14. High fructose diet increases mortality in hypertensive rats compared to a complex carbohydrate or high fat diet.
    Sharma N, Okere IC, Duda MK, Johnson J, Yuan CL, Chandler MP, Ernsberger P, Hoit BD, Stanley WC.
    Am J Hypertens; 2007 Apr 24; 20(4):403-9. PubMed ID: 17386347
    [Abstract] [Full Text] [Related]

  • 15. Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.
    Zhou N, Li L, Wu J, Gong H, Niu Y, Sun A, Ge J, Zou Y.
    Biochem Biophys Res Commun; 2010 Jun 25; 397(2):263-9. PubMed ID: 20580688
    [Abstract] [Full Text] [Related]

  • 16. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
    Horinaka S, Kobayashi N, Yagi H, Mori Y, Matsuoka H.
    J Cardiovasc Pharmacol; 2006 May 25; 47(5):629-35. PubMed ID: 16775500
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
    Obata K, Nagata K, Iwase M, Odashima M, Nagasaka T, Izawa H, Murohara T, Yamada Y, Yokota M.
    Biochem Biophys Res Commun; 2005 Dec 16; 338(2):1299-305. PubMed ID: 16256941
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.
    Sakata Y, Masuyama T, Yamamoto K, Nishikawa N, Yamamoto H, Kondo H, Ono K, Otsu K, Kuzuya T, Miwa T, Takeda H, Miyamoto E, Hori M.
    Circulation; 2000 Oct 31; 102(18):2269-75. PubMed ID: 11056104
    [Abstract] [Full Text] [Related]

  • 19. High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat.
    Okere IC, Chess DJ, McElfresh TA, Johnson J, Rennison J, Ernsberger P, Hoit BD, Chandler MP, Stanley WC.
    Clin Exp Pharmacol Physiol; 2005 Oct 31; 32(10):825-31. PubMed ID: 16173943
    [Abstract] [Full Text] [Related]

  • 20. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
    Ennis IL, Garciarena CD, Escudero EM, Pérez NG, Dulce RA, Camilión de Hurtado MC, Cingolani HE.
    Can J Physiol Pharmacol; 2007 Oct 31; 85(3-4):301-10. PubMed ID: 17612638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.